Raw materials in the manufacture of biotechnology products: regulatory considerations
{{output}}
The Food and Drug Administration's Pharmaceutical cGMPs for the 21st Century initiative emphasizes science and risk-based approaches in the manufacture of drugs. These approaches are reflected in the International Conference on Harmonization (ICH) guidances IC... ...
